Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Other Long-Term Liabilities : $0.00 Mil (As of Apr. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Advanced Proteome Therapeutics Other Long-Term Liabilities?

Advanced Proteome Therapeutics's other long-term liabilities for the quarter that ended in Apr. 2023 was $0.00 Mil.

Advanced Proteome Therapeutics's quarterly other long-term liabilities increased from Oct. 2022 ($-0.00 Mil) to Jan. 2023 ($-0.00 Mil) and increased from Jan. 2023 ($-0.00 Mil) to Apr. 2023 ($0.00 Mil).

Advanced Proteome Therapeutics's annual other long-term liabilities increased from Jul. 2020 ($0.26 Mil) to Jul. 2021 ($1.79 Mil) but then declined from Jul. 2021 ($1.79 Mil) to Jul. 2022 ($0.02 Mil).

Advanced Proteome Therapeutics Other Long-Term Liabilities Historical Data

The historical data trend for Advanced Proteome Therapeutics's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Other Long-Term Liabilities Chart

Advanced Proteome Therapeutics Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Other Long-Term Liabilities

Get a 7-Day Free Trial

Advanced Proteome Therapeutics Quarterly Data
	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Advanced Proteome Therapeutics Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Advanced Proteome Therapeutics Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (OTCPK:APTCF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

0E81:Germany APC.H:Canada

Address

8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2

Website

https://www.advancedproteome.com

Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (Advanced Proteome Therapeutics) Headlines

From GuruFocus

Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement

By GlobeNewswire GlobeNewswire • 08-23-2018

Advanced Proteome Therapeutics Announces Appointment of Bill Dickie as Chief Executive Officer, President and Director

By GlobeNewswire GlobeNewswire • 06-06-2018